Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia
· Delayed Price · Currency is AUD 0.250
0.00 (0.00%)
Mar 10, 2026, 10:39 AM AEST
ASX:PAR Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 14.66 | 16.82 | 17.82 | 56.33 | 39.67 | 71.03 | Upgrade
|
| Short-Term Investments | 0.07 | - | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Cash & Short-Term Investments | 14.74 | 16.82 | 17.87 | 56.38 | 39.72 | 71.08 | Upgrade
|
| Cash Growth | -40.53% | -5.87% | -68.31% | 41.94% | -44.12% | -32.09% | Upgrade
|
| Accounts Receivable | - | - | - | - | - | 0.02 | Upgrade
|
| Other Receivables | 6.31 | 6.37 | 6.07 | 6.81 | 6.72 | 8.49 | Upgrade
|
| Receivables | 6.31 | 6.37 | 6.07 | 6.81 | 6.72 | 8.51 | Upgrade
|
| Prepaid Expenses | 0.62 | 0.94 | 1.3 | 0.6 | 0.73 | 1.39 | Upgrade
|
| Total Current Assets | 21.67 | 24.13 | 25.24 | 63.79 | 47.17 | 80.98 | Upgrade
|
| Property, Plant & Equipment | 0.58 | 0.03 | 0.19 | 0.34 | 0.57 | 0.76 | Upgrade
|
| Other Intangible Assets | 0.91 | 0.41 | 2.95 | 2.95 | 2.95 | 2.95 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | - | 0.1 | Upgrade
|
| Total Assets | 23.15 | 24.57 | 28.37 | 67.07 | 50.69 | 84.79 | Upgrade
|
| Accounts Payable | 4.44 | 2.73 | 2.82 | 12.16 | 7.09 | 4.99 | Upgrade
|
| Accrued Expenses | 0.58 | 0.49 | 0.42 | 0.78 | 0.59 | 0.67 | Upgrade
|
| Short-Term Debt | 8.8 | - | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.14 | 0.01 | 0.12 | 0.1 | 0.15 | 0.13 | Upgrade
|
| Total Current Liabilities | 16.6 | 3.23 | 3.36 | 13.04 | 7.83 | 5.79 | Upgrade
|
| Long-Term Leases | 0.44 | - | 0.12 | 0.24 | 0.47 | 0.62 | Upgrade
|
| Pension & Post-Retirement Benefits | 0.12 | - | - | - | 0.08 | - | Upgrade
|
| Other Long-Term Liabilities | - | 0.15 | 0.11 | 0.11 | - | 0.11 | Upgrade
|
| Total Liabilities | 17.16 | 3.39 | 3.58 | 13.39 | 8.38 | 6.52 | Upgrade
|
| Common Stock | 260.87 | 253.23 | 238.11 | 209.83 | 147.19 | 146.99 | Upgrade
|
| Retained Earnings | -258.64 | -235.95 | -219.75 | -163.51 | -114.02 | -75.23 | Upgrade
|
| Comprehensive Income & Other | 3.77 | 3.9 | 6.42 | 7.36 | 9.13 | 6.51 | Upgrade
|
| Shareholders' Equity | 6 | 21.18 | 24.79 | 53.68 | 42.31 | 78.27 | Upgrade
|
| Total Liabilities & Equity | 23.15 | 24.57 | 28.37 | 67.07 | 50.69 | 84.79 | Upgrade
|
| Total Debt | 9.38 | 0.01 | 0.24 | 0.34 | 0.62 | 0.75 | Upgrade
|
| Net Cash (Debt) | 5.36 | 16.81 | 17.63 | 56.04 | 39.1 | 70.33 | Upgrade
|
| Net Cash Growth | -78.22% | -4.62% | -68.54% | 43.30% | -44.40% | -32.22% | Upgrade
|
| Net Cash Per Share | 0.02 | 0.05 | 0.06 | 0.22 | 0.17 | 0.31 | Upgrade
|
| Filing Date Shares Outstanding | 428.52 | 397.43 | 350.36 | 281.76 | 234.25 | 229.91 | Upgrade
|
| Total Common Shares Outstanding | 428.52 | 389.43 | 350.36 | 281.76 | 232.68 | 229.91 | Upgrade
|
| Working Capital | 5.07 | 20.89 | 21.88 | 50.74 | 39.34 | 75.18 | Upgrade
|
| Book Value Per Share | 0.01 | 0.05 | 0.07 | 0.19 | 0.18 | 0.34 | Upgrade
|
| Tangible Book Value | 5.09 | 20.77 | 21.84 | 50.73 | 39.37 | 75.33 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | 0.05 | 0.06 | 0.18 | 0.17 | 0.33 | Upgrade
|
| Machinery | - | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | Upgrade
|
| Leasehold Improvements | - | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.